Cervical spondylosis / chronic neck pain supplement stack — what helps inflammation and what doesn't
Cervical spondylosis is age-related degenerative change in the cervical vertebrae and intervertebral discs, almost universal on imaging by the sixth decade. Symptoms range from intermittent neck stiffness and occipital headache through chronic mechanical neck pain to (less commonly) radiculopathy from neural foraminal narrowing or myelopathy from canal stenosis. The supplement evidence in chronic neck pain is largely extrapolated from the osteoarthritis literature — there is essentially no neck-pain-specific high-quality supplement RCT — but the inflammatory and connective-tissue mechanisms overlap meaningfully. Active management (exercise, posture, and physiotherapy) dominates outcomes; supplements are adjunctive.
What actually has trial-grade evidence (extrapolated from OA)
Curcumin (bioavailable formulation)
500 mg b.i.d. of a bioavailable curcumin (phytosome, BCM-95, Meriva, similar)
Multiple knee-OA meta-analyses show modest pain reduction comparable to NSAIDs. Mechanism (NF-κB pathway modulation, reduced cytokine output) is plausibly relevant in chronic cervical OA pain. Bioavailability is the rate-limit — buying generic turmeric powder will not replicate trial dosing. Take with fat-containing meals. Discuss with prescriber if on anticoagulants.
Boswellia serrata (AKBA-enriched)
100 mg b.i.d. of AKBA-enriched Boswellia (Apresflex/Aflapin) or 250 mg b.i.d. of standard 5-Loxin
5-lipoxygenase inhibition reduces leukotriene-driven inflammation. Knee-OA RCTs show pain and function improvement with relatively rapid (7–14 days) onset. AKBA-enriched extracts are better characterised in modern trials.
Omega-3 (EPA/DHA)
1–2 g EPA+DHA/day with a fat-containing meal
General anti-inflammatory effect; multiple OA and chronic inflammatory pain trials. Reasonable foundation for any chronic inflammatory pain condition.
Magnesium glycinate (muscle tone, sleep, comorbid migraine)
400 mg elemental at bedtime
Cervicogenic muscle tension and comorbid migraine are common in chronic neck pain. Magnesium addresses both. Glycinate is well-tolerated for chronic use without laxative effect.
Vitamin D3 (when 25-OH-D is low)
2,000–4,000 IU/day to a 25-OH-D target of 30–50 ng/mL
Vitamin D deficiency is more prevalent in chronic musculoskeletal pain cohorts. Correction reduces musculoskeletal pain in deficient patients. Test 25-OH-D and target.
PEA (palmitoylethanolamide) and acetyl-L-carnitine — for cervical radiculopathy
PEA 600 mg b.i.d. (micronised or ultra-micronised); ALCAR 1000 mg b.i.d.
If the picture includes radicular arm pain, PEA has small trial signal in lumbosacral radiculopathy that has been extrapolated to cervical radicular pain. ALCAR has signal in diabetic peripheral neuropathy and is reasonable in nerve-pain phenotypes. Both are well-tolerated.
The active rehabilitation base — by far the largest lever
For chronic mechanical neck pain, supplements are a small fraction of total benefit; these interventions are where the real outcome moves live:
- Deep cervical flexor training — the chin-tuck and progressive deep neck flexor protocols (Jull, O'Leary) have the cleanest evidence in chronic neck pain.
- Scapular stabilisation — lower trapezius, serratus anterior, rhomboids; addresses the upper-cross postural pattern that loads the cervical spine.
- Thoracic mobility — restricted thoracic kyphosis pushes load to the cervical spine; foam rolling and thoracic extension drills.
- Ergonomic correction — monitor at eye level, supportive chair, headset for prolonged calls, neutral wrist position; "tech neck" is real and addressable.
- Aerobic exercise (moderate intensity, 150+ min/week) — general anti-inflammatory effect; better-evidenced for chronic pain than any supplement.
- Sleep position — supportive pillow (cervical contour or appropriate height); side-sleeping with head-neck alignment.
- Stress and pain catastrophising — CBT and ACT-based approaches reduce chronic pain meaningfully.
- Smoking cessation — smoking impairs disc nutrition; cessation slows degenerative progression.
- Weight management — modest reductions in BMI reduce mechanical load on the cervical spine in obese patients.
- Manual therapy and physiotherapy — short-term symptom relief; combine with active rehabilitation.
What to skip
- Glucosamine/chondroitin for the cervical spine specifically — these are best-evidenced in knee OA; cervical OA trials are essentially absent and meta-analytic effects in knee are modest.
- High-dose NSAID stacking with curcumin and Boswellia long-term — additive bleeding and GI risk; consider the inflammatory load you're managing.
- Generic "joint complex" megaformulas — typically deliver sub-therapeutic doses of multiple ingredients; better to buy single-ingredient products at trial doses.
- "Disc regeneration" supplements with stem cell or stromal-cell-promoting marketing — not supported by trial evidence.
- High-dose vitamin C as cartilage protectant — physiologic doses are appropriate for everyone; megadoses for joint protection are not evidence-based.
- Heavy reliance on opioids for chronic neck pain — not first-line; significant downstream harms; address the mechanical and active-rehabilitation drivers instead.
- Repeated cervical manipulation in patients on anticoagulants or with vascular risk factors — rare but serious vertebral artery dissection reports exist.
What to track
Use the Neck Disability Index (NDI) — a validated 10-item questionnaire. Track NDI monthly. Pair with pain score (0–10 NRS) at rest, with activity, and at end of day. Photograph postural alignment at 4–8 week intervals. The clinically meaningful response is typically 5+ point NDI reduction or 30% pain reduction at 8–12 weeks of consistent active rehabilitation. Supplements alone rarely move NDI; layered on the active rehabilitation base, modest additional improvement is realistic.